This inventor holds 2 USPTO granted patents. Top assignee: Baylor College of Medicine. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2002
Title: Richard R. Dickason: Innovator in Monoclonal Antibodies
Introduction
Richard R. Dickason is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work focuses on innovative solutions for treating inflammatory conditions.
Latest Patents
Richard's latest patents include monoclonal antibodies specific for human interleukin-5. These antibodies are designed to bind specifically to human interleukin-5 (IL-5) and are described for the treatment of IL-5-mediated inflammatory conditions. Additionally, fragments or chimeric binding molecules derived from these monoclonal antibodies are also detailed for use. His work on these antibodies extends to their application in assays for IL-5, purifying IL-5, and characterizing IL-5.
Career Highlights
Richard R. Dickason is affiliated with Baylor College of Medicine, where he continues to advance research in his field. His innovative approaches have positioned him as a key figure in the development of therapeutic antibodies.
Collaborations
Some of Richard's notable coworkers include Marilyn M. Huston and David P. Huston. Their collaborative efforts contribute to the ongoing research and development in monoclonal antibody technology.
Conclusion
Richard R. Dickason's work in monoclonal antibodies represents a significant advancement in the treatment of inflammatory conditions. His contributions to biotechnology continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile